Esteban Gonzalez Burchard and colleagues explore how making medical research more
diverse would aid not only social justice but scientific quality and clinical effectiveness, too.

Sarcopenia is an age-related disease associated with loss of muscle mass and strength. This
geriatric syndrome predisposes elderly individuals to a disability, falls, fractures, and death…

Myostatin inhibition therapy has held much promise for the treatment of muscle wasting
disorders. This is particularly true for the fatal myopathy, Duchenne Muscular Dystrophy (DMD). …

As the principal energy-producing organelles of the cell, mitochondria support numerous
biological processes related to metabolism, growth, and regeneration in skeletal muscle. …

New medicines are urgently required to treat the fatal neuromuscular disease Duchenne
muscular dystrophy (DMD). Dimethyl fumarate (DMF) is a potent immunomodulatory small …

Spontaneous preterm birth is the leading cause of perinatal morbidity and mortality.
Tocolytics are drugs used in cases of imminent preterm birth to inhibit uterine contractions. …

Supplementation with vitamin D helps to alleviate weakness and fatigue seen with deficiency.
However, large bolus doses appear to worsen the risk of falls. Whether this occurs as a …

Vitamin D is commonly prescribed to normalize deficiencies and to treat osteoporosis. However,
the effect vitamin D supplements have on skeletal muscle health is equivocal. Although …

Osteosarcopenic individuals have poor muscle function and increased bone fragility, which
results in a severe detriment to health outcomes. Hence, there is a necessity to discover …

Vitamin D (VitD) has shown to be beneficial in reversing muscle weakness and atrophy
associated with VitD deficiency. Duchenne muscular dystrophy is characterized by worsening …